07/15/2021 5:59 PM
Clarín.com
Politics
Updated 07/15/2021 6:19 PM
Alberto Fernández announced the approval of the Gamaleya Institute of Russia for the production of Sputnik V vaccines in Argentina.
He did so in a videoconference with the president of
Richmond laboratories
, Marcelo Figueiras.
"
Congratulations, Marcelo
. I have here the approval of the arrival of Russia," the President congratulated Figueiras.
The CEO of Richmond was "proud" by the approval "to the first industrial batch that will be used in our country".
He announced that,
when ANMAT issues its approval
,
140,625 doses of component 1
of Sputnik V prepared at the Pilar plant
will begin to be distributed
.
"And the rest will be released shortly," added Figueiras.
Videoconference between Alberto Fernández and the president of Richmond laboratories.
"I am proud. We have 1.3 million doses of component 1 and
1.01 million of component 2,
" he added about the production achieved so far.
In turn, Alberto Fernández described the news as an "infinite advance".
"
The progress you have made is infinite
. We have taken a very important step," said the president.
"It was done by a
private company
, the State helped it in everything in its power. But the credit goes to the private company. And the truth in a sad day for having exceeded 100,000 deaths. The best tribute is to take care of those who are and the best thing is to make the vaccine in Argentina ", added the President.
Minister Vizzotti together with the directors of Laboratorios Richmond presented the first production of the Sputnik V vaccine in our country.
In addition, he said that Argentina "always distinguished itself by its scientists," but added that "there is always a need for the businessman to help channel the effort."
After thanking Figueiras again, he completed: "Argentina was in need of these vaccines. The pandemic will endure, it will take time to cope with it, but the vaccine gives us a lot of peace of mind and guarantees that if we get infected the pain will be less" .
How the vaccination works
The vaccines produced by Richmond are made with the antigen brought from Russia.
Formulation, filtering and packaging are made in our country.
The first batches of Sputnik V component 1 were made in two batches at the Richmond plant in Pilar: 448,625 doses (on June 18) and another 550,000 doses (on July 2).
From these consignments came the samples sent to the Gamaleya National Research Center for Epidemiology and Microbiology, of the Russian Federation, in search of its approval.
Alberto Fernández and Carla Vizzotti, on a visit to the Richmond laboratories plant in Pilar.
photo Presidency
"Gamaleya promised to finish his final verifications as soon as possible, but they have many analyzes to do," Figueiras had said weeks ago.
And he remarked: "We have the
tranquility of having checked it
ourselves and that they gave everything well."
At the beginning of June, Figueiras himself assured that Richmond is in a position to produce
500 thousand doses
of the Russian vaccine
per week.
Until now, Argentina has received 31,255,730 doses, of which 11,868,830 correspond to Sputnik V, (9,375,670 for component 1 and 2,493,160 for component 2);
9,072,000 to Sinopharm;
580,000 to AstraZeneca-Covishield, 1,944,000 to AstraZeneca through the WHO COVAX mechanism.
There are also 7,790,900 doses of AstraZeneca and Oxford, whose active ingredient was produced locally, in Hugo Sigman's mAbxience laboratory, and whose packaging is carried out in Mexico and the United States.
After long delays, the finished product began arriving in Argentina on June 12.
In addition, agreements have already been reached for the CanSino vaccines (they would arrive in the coming weeks) and Moderna (they would arrive in 2022, although they could be advanced through donations).
26,134,815 doses have already been applied in the country: 20,985,921 people have a single application, while another 5,148,894 people completed the planned scheme.
DS
Look also
Alberto Fernández, on the 100,000 deaths from coronavirus: "There are those who negotiate with those deaths"
Vaccination in boys: Carla Vizzotti said that they already evaluate it and first it will be between 12 and 17 years old
